title: Reply by the authors.
authors.forename: Demet
authors.initials: D
authors.lastname: Alaygut
authors.forename: Alper
authors.initials: A
authors.lastname: Soylu
authors.forename: Belde
authors.initials: B
authors.lastname: Kasap
authors.forename: Mehmet
authors.initials: M
authors.lastname: Türkmen
authors.forename: Salih
authors.initials: S
authors.lastname: Kavukcu
mesh_terms: D001827:Body Height; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007668:Kidney / Q000473:pathology* / Q000503:physiopathology*; D008297:Male; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
chemical_list: D019274:Botulinum Toxins, Type A; C542869:abobotulinumtoxinA